0001144204-15-007966.txt : 20150211 0001144204-15-007966.hdr.sgml : 20150211 20150211164102 ACCESSION NUMBER: 0001144204-15-007966 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20150211 DATE AS OF CHANGE: 20150211 EFFECTIVENESS DATE: 20150211 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SiGNa Chemistry, Inc. CENTRAL INDEX KEY: 0001632876 IRS NUMBER: 208748774 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-233936 FILM NUMBER: 15600093 BUSINESS ADDRESS: STREET 1: 445 PARK AVENUE STREET 2: SUITE 937 CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: (212) 933-4101 MAIL ADDRESS: STREET 1: 445 PARK AVENUE STREET 2: SUITE 937 CITY: NEW YORK STATE: NY ZIP: 10022 D 1 primary_doc.xml X0707 D LIVE 0001632876 SiGNa Chemistry, Inc. 445 PARK AVENUE SUITE 937 NEW YORK NY NEW YORK 10022 (212) 933-4101 DELAWARE None None Corporation true Michael Lefenfeld 445 Park Avenue Suite 937 New York NY NEW YORK 10022 Executive Officer Director Promoter Jeffrey Seidel 445 Park Avenue Suite 937 New York NY NEW YORK 10022 Executive Officer Nael Kassar 445 Park Avenue Suite 937 New York NY NEW YORK 10022 Director Mark A. Lester 445 Park Avenue Suite 937 New York NY NEW YORK 10022 Director Katherine Carney 445 Park Avenue Suite 937 New York NY NEW YORK 10022 Executive Officer Peter Cash 445 Park Avenue Suite 937 New York NY NEW YORK 10022 Executive Officer Mack Knobbe 445 Park Avenue Suite 937 New York NY NEW YORK 10022 Executive Officer Paul Krumrine 445 Park Avenue Suite 937 New York NY NEW YORK 10022 Executive Officer Manufacturing Decline to Disclose 06b false 2015-01-27 false true true false 0 24513269 24513269 0 Amount sold includes $4,513,269 which was converted from debt to equity. As part of offering, one Investor also acquired a Warrant to purchase Series D-1 Preferred Stock. false 7 0 0 0 false SiGNa Chemistry, Inc. /s/ Michael Lefenfeld Michael Lefenfeld President 2015-02-11